首页> 美国卫生研究院文献>Dentistry Journal >An Evaluation of the Accuracy of the Subtraction Method Used for Determining Platelet Counts in Advanced Platelet-Rich Fibrin and Concentrated Growth Factor Preparations
【2h】

An Evaluation of the Accuracy of the Subtraction Method Used for Determining Platelet Counts in Advanced Platelet-Rich Fibrin and Concentrated Growth Factor Preparations

机译:用于确定富含血小板的纤维蛋白和浓缩生长因子制剂中血小板计数的减法方法的准确性评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Platelet concentrates should be quality-assured of purity and identity prior to clinical use. Unlike for the liquid form of platelet-rich plasma, platelet counts cannot be directly determined in solid fibrin clots and are instead calculated by subtracting the counts in other liquid or semi-clotted fractions from those in whole blood samples. Having long suspected the validity of this method, we herein examined the possible loss of platelets in the preparation process. Blood samples collected from healthy male donors were immediately centrifuged for advanced platelet-rich fibrin (A-PRF) and concentrated growth factors (CGF) according to recommended centrifugal protocols. Blood cells in liquid and semi-clotted fractions were directly counted. Platelets aggregated on clot surfaces were observed by scanning electron microscopy. A higher centrifugal force increased the numbers of platelets and platelet aggregates in the liquid red blood cell fraction and the semi-clotted red thrombus in the presence and absence of the anticoagulant, respectively. Nevertheless, the calculated platelet counts in A-PRF/CGF preparations were much higher than expected, rendering the currently accepted subtraction method inaccurate for determining platelet counts in fibrin clots. To ensure the quality of solid types of platelet concentrates chairside in a timely manner, a simple and accurate platelet-counting method should be developed immediately.
机译:临床使用前,应对浓缩血小板的纯度和特性进行质量保证。与液态形式的富含血小板的血浆不同,血小板计数不能直接在固体纤维蛋白凝块中测定,而是通过从全血样本中减去其他液体或半凝块馏分中的计数来计算。长期以来,人们一直怀疑这种方法的有效性,因此我们在本文中研究了制备过程中血小板的可能损失。根据推荐的离心方案,将从健康男性供体中收集的血液样品立即离心,以分离出高级的富含血小板的纤维蛋白(A-PRF)和浓缩的生长因子(CGF)。直接计数液体和半凝块级分中的血细胞。通过扫描电子显微镜观察在凝块表面上聚集的血小板。在存在和不存在抗凝剂的情况下,较高的离心力分别增加了液体红细胞部分和半凝集的红色血栓中的血小板和血小板聚集物的数量。然而,A-PRF / CGF制剂中计算出的血小板计数远高于预期,这使得当前接受的减影方法无法确定血纤蛋白凝块中的血小板计数。为确保及时在床旁浓缩固体浓缩血小板的质量,应立即开发一种简单准确的血小板计数方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号